Your Health, We Care
Adverse reactions occurring in ≥ 1% of patients on Finerenone and more frequently than placebo are hyperkalemia, hypotension, and hyponatremia.
来自FDA，2022.09
Regarding the safety of finerenone, there have been systematic research conclusi···【more】
Release date：2025-04-22Recommended：22
Regarding the safety of finerenone, there have been systematic research conclusi···【more】
Release date：2025-04-21Recommended：30
In the field of chronic disease treatment, the application of the new drug finer···【more】
Release date：2025-04-21Recommended：28
